Imidazole

Imidazole

SCHEMBL3503281

P.c1c[nH]cn1.c1c[nH]cn1.c1c[nH]cn1

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.93
▸ FKBP5 Q13451 1/20 0.93

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Imidazole SCHEMBL5317575 1.00 ALDH1A1 (0.93) ALDH1A1FKBP5
Imidazole SCHEMBL1130092 1.00 — —
Imidazole SCHEMBL27893028 0.97 — —
Imidazole SCHEMBL27941696 0.97 ALDH1A1 (0.87) ALDH1A1FKBP5
Imidazole SCHEMBL28178838 0.97 — —
Imidazole SCHEMBL5333604 0.97 ALDH1A1 (0.87) ALDH1A1FKBP5
Imidazole SCHEMBL1445454 0.97 — —
Imidazole SCHEMBL28412052 0.97 — —
Imidazole SCHEMBL29154119 0.97 — —
Imidazole SCHEMBL897 0.96 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678542-B2 Charge tags and the separation of nucleic acid molecules THIRD WAVE TECHNOLOGIES, INC. (US) 2010-03-16 — — US disclosed
US-20090078574-A1 CHARGE TAGS AND THE SEPARATION OF NUCLEIC ACID MOLECULES THIRD WAVE TECHNOLOGIES, INC. (US) 2009-03-26 — — US disclosed
EP-1385996-B1 Charge tag and separation of nucleic acid molecules THIRD WAVE TECH INC (US) 2008-08-06 — — EP disclosed
US-7384746-B2 Charge tags and the separation of nucleic acid molecules THIRD WAVE TECHNOLOGIES, INC. (US) 2008-06-10 — — US disclosed
EP-0904275-B1 PREPARATION OF PHOSPHOROTHIOATE OLIGOMERS UNIV MCGILL (CA) 2006-05-17 — — EP disclosed
EP-1112281-B1 PTERIDINE NUCLEOTIDE ANALOGS US GOV HEALTH & HUMAN SERV (US) 2005-11-23 — — EP disclosed
US-20050130179-A1 Charge tags and the separation of nucleic acid molecules THIRD WAVE TECHNOLOGIES, INC. (US) 2005-06-16 — — US disclosed
US-6861518-B2 Hybrid oligonucleotide MCGILL UNIVERSITY (CA) 2005-03-01 — — US disclosed
US-6780982-B2 COMPOSITION FOR USE AS DETECTION AND SEPARATION TOOLS IN NUCLEOTIDE SEQUENCES ANALYSIS THIRD WAVE TECHNOLOGIES, INC. 2004-08-24 — — US disclosed
US-20040097722-A9 Preparation of phosphorothioate oligomers MCGILL UNIVERSITY 2004-05-20 — — US disclosed
WO-2000000499-A1 METHOD FOR PREPARING OLIGONUCLEOTIDES WITH BORANOPHOSPHATE LINKAGES ISIS PHARMACEUTICALS, INC. (US) 2000-01-06 — — WO disclosed
US-5945521-A Preparation of phosphorothioate oligomers MCGILL UNIVERSITY (CA) 1999-08-31 — — US disclosed
EP-0904275-A1 PREPARATION OF PHOSPHOROTHIOATE OLIGOMERS McGILL UNIVERSITY (CA) 1999-03-31 — — EP disclosed
EP-0759927-B1 PTERIDINE NUCLEOTIDE ANALOGS AS FLUORESCENT DNA PROBES US GOV HEALTH & HUMAN SERV (US) 1998-06-24 — — EP disclosed
US-5734041-A Preparation of chiral phosphorothioate oligomers MCGILL UNIVERSITY (CA) 1998-03-31 — — US disclosed
WO-1997014710-A1 PREPARATION OF PHOSPHOROTHIOATE OLIGOMERS MCGILL UNIVERSITY (US) 1997-04-24 — — WO disclosed
US-5612468-A GENETIC ENGINEERING THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-03-18 — — US disclosed
EP-0759927-A1 PTERIDINE NUCLEOTIDE ANALOGS AS FLUORESCENT DNA PROBES THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-03-05 — — EP disclosed
US-5525711-A MONOMERS FOR DNA AMPLIFICATION PROCEDURES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-06-11 — — US disclosed
WO-1995031469-A1 PTERIDINE NUCLEOTIDE ANALOGS AS FLUORESCENT DNA PROBES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1995-11-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130179-A1 Charge tags and the separation of nucleic acid molecules NSUN2, NSUN3, NCL ALDH1A1 3799/4885FKBP5 2620/4885
US-20090078574-A1 CHARGE TAGS AND THE SEPARATION OF NUCLEIC ACID MOLECULES NSUN2, NSUN3, NCL ALDH1A1 3799/4885FKBP5 2620/4885
US-20040097722-A9 Preparation of phosphorothioate oligomers RNGTT, NUDT1, OSGEP ALDH1A1 3421/4885FKBP5 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback